Johnson & Johnson develops pharmaceutical products and medical devices targeting major disease areas including cancer, immune disorders, and cardiovascular conditions. Its portfolio includes prescription medicines and technologies used in surgery, orthopedics, and diagnostics. Healthcare systems and patients worldwide use these products, supported by the company's clinical development programs and manufacturing capabilities.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 23,743 | — | 5,537 | -19% |
| Q3 2025 | 23,993 | — | 5,152 | -11.6% |
| Q4 2025 | 24,564 | — | 5,116 | 4.2% |
| Q1 2026 | 24,062 | — | 5,235 | -21.6% |
| Q2 2026 | 25,310 | 6.6% | 5,534 | -0.1% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Mastercard Incorporated (MA), AbbVie Inc. (ABBV), Chevron Corporation (CVX), The Coca-Cola Company (KO), Oracle Corporation (ORCL), The Procter & Gamble Company (PG)